Exact Therapeutics AS (EXTX) — Financial Flexibility Index
Exact Therapeutics AS (EXTX) has a Financial Flexibility Index of -2.10x as of December 2024. Free cash flow of Nkr-79.04 Million (operating CF Nkr-80.55 Million minus capex Nkr1.51 Million) represents -2% of total liabilities (Nkr37.65 Million). Check tangible equity quality of Exact Therapeutics AS to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Exact Therapeutics AS Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Exact Therapeutics AS across 8 annual periods. For the full cash flow conversion analysis, see Exact Therapeutics AS cash flow conversion.
Annual Financial Flexibility Index for Exact Therapeutics AS (2017–2024)
Year-by-year free cash flow to debt coverage for Exact Therapeutics AS. Explore Exact Therapeutics AS (EXTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.10x | Nkr-79.04 Million | Nkr-80.55 Million | Nkr37.65 Million | ▲ +17.4% |
| 2023 | -2.54x | Nkr-41.20 Million | Nkr-44.30 Million | Nkr16.22 Million | ▼ -31.6% |
| 2022 | -1.93x | Nkr-33.60 Million | Nkr-33.85 Million | Nkr17.40 Million | ▲ +57.1% |
| 2021 | -4.50x | Nkr-53.48 Million | Nkr-55.11 Million | Nkr11.89 Million | ▼ -116.1% |
| 2020 | -2.08x | Nkr-22.03 Million | Nkr-25.99 Million | Nkr10.58 Million | ▼ -85.7% |
| 2019 | -1.12x | Nkr-11.07 Million | Nkr-12.46 Million | Nkr9.87 Million | ▲ +37.5% |
| 2018 | -1.79x | Nkr-11.07 Million | Nkr-12.46 Million | Nkr6.17 Million | ▼ -89.2% |
| 2017 | -0.95x | Nkr-11.07 Million | Nkr-12.46 Million | Nkr11.68 Million | — |